arXiv subjects

Elisabetta Marini

Publications and source records attributed to Elisabetta Marini.

3 recordsLinked to original sources

arXiv2026

Experimental Characterization of Biological Tissue Dielectric Properties through THz Time-Domain Spectroscopy

Terahertz (THz) radiation provides a non-ionizing, highly sensitive probe of the dielectric properties of biological tissues. In this study, we present a comprehensive experimental characterization of dielectric properties using pork skin tissue, a widely used surrogate for human tissue, as a biological sample. Measurements are conducted employing THz time-domain spectroscopy in the 0.1-11 THz frequency range with photoconductive antennas for both signal generation and detection. Frequency-dependent refractive indices, absorption, and complex permittivity are extracted from transmitted time-domain signals. Our results confirm strong absorption and low transmittance at low THz frequencies due to water content, while highlighting frequency-dependent dispersion and narrowband transmission features at higher frequencies. This work provides one of the first extended-frequency datasets of biological tissue dielectric properties, supporting realistic channel modeling for the design and development of intra-body nanosensor networks in the THz band.

physics.optics↗

arXiv2026

Layered Dielectric Characterization of Human Skin in the Sub-Terahertz and Terahertz Frequency Ranges

Sub-terahertz (sub-THz) and terahertz (THz) radiation offer unique opportunities for non-invasive diagnostics and imaging due to their sensitivity to water content and molecular dynamics in biological tissues. In this work, a comprehensive dielectric model of human skin and its cellular constituents is developed across these frequency ranges. The model combines multi-Debye relaxation theory with effective medium formulations to account for intracellular water dynamics and macromolecular relaxation processes. Key cellular parameters, including water content, protein and lipid fractions, and ionic conductivity, are integrated from experimentally validated sources. The proposed framework enables realistic predictions of frequency-dependent permittivity for different skin layers and cell types, providing a physically interpretable description of sub-THz and THz tissue interactions. This approach establishes a foundation for the design and optimization of next-generation diagnostic and imaging techniques operating in these frequency bands.

cs.ET↗

arXiv2023

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation

Inspired by the recent advancements in understanding the binding mode of sulfonylurea-based NLRP3 inhibitors to the NLRP3 sensor protein, we developed new NLRP3 inhibitors by replacing the central sulfonylurea moiety with different heterocycles. Computational studies evidenced that some of the designed compounds were able to maintain important interaction within the NACHT domain of the target protein similarly to the most active sulfonylurea-based NLRP3 inhibitors. Among the studied compounds, the 1,3,4-oxadiazol-2-one derivative 5 (INF200) showed the most promising results being able to prevent NLRP3-dependent pyroptosis triggered by LPS/ATP and LPS/MSU by 66.3 +/- 6.6% and 61.6 +/- 11.5% and to reduce IL-1\b{eta} release (35.5 +/- 8.8 % μM) at 10 μM in human macrophages. The selected compound INF200 (20 mg/kg/day) was then tested in an in vivo rat model of high-fat diet (HFD)-induced metaflammation to evaluate its beneficial cardiometabolic effects. INF200 significantly counteracted HFD-dependent "anthropometric" changes, improved glucose and lipid profiles, and attenuated systemic inflammation and biomarkers of cardiac dysfunction (particularly BNP). Hemodynamic evaluation on Langendorff model indicate that INF200 limited myocardial damage-dependent ischemia/reperfusion injury (IRI) by improving post-ischemic systolic recovery and attenuating cardiac contracture, infarct size, and LDH release, thus reversing the exacerbation of obesity-associated damage. Mechanistically, in post-ischemic hearts, IFN200 reduced IRI-dependent NLRP3 activation, inflammation, and oxidative stress. These results highlight the potential of the novel NLRP3 inhibitor, INF200, and its ability to reverse the unfavorable cardio-metabolic dysfunction associated with obesity.

physics.bio-ph↗